Last update 04 Apr 2026

ECI-830

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms-
Target
CDK2
Action
inhibitors
Mechanism
CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Advanced Malignant Solid NeoplasmHormone receptor positive HER2 negative breast cancer
Inactive Indication-
Originator Organization
Novartis Pharmaceuticals Corp.Novartis Pharmaceuticals Corp.
Active Organization
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.Novartis Pharma AGNovartis AGNovartis AG
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ECI-830
NCT06726148
/ RecruitingPhase 1/2
An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors
100 Clinical Results associated with ECI-830
Login to view more data
100 Translational Medicine associated with ECI-830
Login to view more data
100 Patents (Medical) associated with ECI-830
Login to view more data
100 Deals associated with ECI-830
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
United States
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
United States
Novartis Pharma AG
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
China
Novartis Pharma AG
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Japan
Novartis Pharma AG
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Japan
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Australia
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Australia
Novartis Pharma AG
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Canada
Novartis Pharma AG
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Canada
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
03 Apr 2025
Advanced Malignant Solid NeoplasmPhase 2
Czechia
Novartis Pharmaceuticals Canada, Inc.Novartis Pharmaceuticals Canada, Inc.
03 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free